Skip to content
Home/Companies/Pharma/Revi Pharma
Revi Pharma

Revi Pharma

Pharma·Italy·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Revi Pharma?

Revi Pharma is currently owned by AVM SGR through Italian Fine Food (2023 vintage), since 2026.

Hand-verified · updated 2026-07-31

AVM SGR
Investor
AVM SGR
Italian Fine Food · 2023 · Growth

Key facts

HQItaly
SectorPharma
StatusActive
Websitewww.revipharma.it

More from Italian Fine Food

Other portfolio companies in the same fund.

Fonte Bracca
Fonte Bracca
Active
ConsumerItaly· 2025
Fonti Pineta
Fonti Pineta
Active
ConsumerItaly· 2025
Heallo
Active
FoodTechItaly· 2024
Stefania Calugi
Active
ConsumerItaly· 2024
Europansud
Active
ConsumerItaly· 2023
Savini Tartufi
Active
ConsumerItaly· 2023

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Revi Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Revi Pharma?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Revi Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue